58468-7840 : Caprelsa 300 mg Oral Tablet


NDC: 58468-7840
Labeler: Genzyme Corporation
Product Type: Human Prescription Drug
Drug Name: Caprelsa
Dosage Form: Oral Tablet
Application #: NDA022405
Rev. Date: 


Appearance:


Markings: Z;300
Shapes:  Oval
Colors:  White
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 58468-7840-3: 1 BOTTLE, PLASTIC IN 1 CARTON (58468‑7840‑3) > 30 TABLET IN 1 BOTTLE, PLASTIC

Active Ingredients:

  • Vandetanib

Dosage Strength:

  • 300 mg

Inactive Ingredients:

  • Dibasic Calcium Phosphate Dihydrate
  • Microcrystalline Cellulose
  • Crospovidone (15 Mpa.s At 5%)
  • Povidone, Unspecified
  • Magnesium Stearate
  • Hypromellose, Unspecified
  • Titanium Dioxide
  • Water
  • Polyethylene Glycol 300

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 58468-7820 Caprelsa 100 mg Oral Tablet by Genzyme Corporation
  • 58468-7860 Caprelsa 300 mg Oral Tablet, Film Coated by Genzyme Corporation
  • 0310-7820 Caprelsa 100 mg Oral Tablet by Astrazeneca Pharmaceuticals Lp
  • 0310-7840 Caprelsa 300 mg Oral Tablet by Astrazeneca Pharmaceuticals Lp

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 58468-7840 QR Code

< Prev: 58468-7820Next: 58468-7860 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.